Biomet Overview

  • Year Founded
  • 1977

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 9,279

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 10

  • Investments
  • 8

Biomet General Information

Description

Manufacturer reconstructive surgery equipment, trauma devices and electrical bone growth stimulators. The company designs and manufactures products used primarily by musculo-skeletal medical specialists in both surgical and non-surgical therapy. Its product portfolio encompasses reconstructive products, fixation devices and spinal products.

Contact Information

Website
www.biomet.com
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 56 East Bell Drive
  • PO Box 587
  • Warsaw, IN 46581-0587
  • United States
+1 (574)
Primary Industry
Surgical Devices
Acquirer
Zimmer Biomet Holdings
Vertical(s)
Corporate Office
  • 56 East Bell Drive
  • PO Box 587
  • Warsaw, IN 46581-0587
  • United States
+1 (574)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biomet Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biomet‘s full profile, request access.

Request a free trial

Biomet Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer reconstructive surgery equipment, trauma devices and electrical bone growth stimulators. The company design
Surgical Devices
Warsaw, IN
9,279 As of 2014

East Providence, RI
 

Naples, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biomet Competitors (47)

One of Biomet’s 47 competitors is IlluminOss, a Private Equity-Backed company based in East Providence, RI.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
IlluminOss Private Equity-Backed East Providence, RI
Arthrex Private Equity-Backed Naples, FL
Atec Spine Formerly PE-Backed Carlsbad, CA
Exactech Private Equity-Backed Gainesville, FL
Orchid Orthopedic Solutions Private Equity-Backed Mason, MI
You’re viewing 5 of 47 competitors. Get the full list »

Biomet Patents

Biomet Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250114171-A1 Hybrid abutment for restorative dental systems, and methods for installing the same Pending 04-Oct-2023
EP-4516262-A1 Pointed countersink drill Pending 30-Aug-2023
US-20230267239-A1 Volume splitting complex shapes Pending 23-Feb-2022
EP-4235480-A1 Volume splitting complex shapes Pending 23-Feb-2022
EP-4205698-A1 Surgical guide check Active 31-Dec-2021 A61C19/04
To view Biomet’s complete patent history, request access »

Biomet Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biomet Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biomet‘s full profile, request access.

Request a free trial

Biomet Investments & Acquisitions (8)

Biomet’s most recent deal was a Buyout/LBO with Lanx for . The deal was made on 01-Nov-2013.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Lanx 01-Nov-2013 Buyout/LBO Surgical Devices
DePuy Orthopaedics (Trauma Business) 16-Jun-2012 Buyout/LBO Therapeutic Devices
SpiTrex Orthopedics 01-Jan-2012 Buyout/LBO BPO/Outsource Services
Cytosol Laboratories 16-Jul-2010 Buyout/LBO Other Pharmaceuticals and Biotechnology
Cartilix 20-Oct-2009 Buyout/LBO Biotechnology
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

Biomet Exits (2)

Biomet’s most recent exit was on 01-Jan-2012 from SpiTrex Orthopedics. The exit was categorized as with 7 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
SpiTrex Orthopedics 01-Jan-2012 Completed
  • 7 buyers
Implex Later Stage VC Completed
  • 5 buyers
To view Biomet’s complete exits history, request access »

Biomet FAQs

  • When was Biomet founded?

    Biomet was founded in 1977.

  • Where is Biomet headquartered?

    Biomet is headquartered in Warsaw, IN.

  • What is the size of Biomet?

    Biomet has 9,279 total employees.

  • What industry is Biomet in?

    Biomet’s primary industry is Surgical Devices.

  • Is Biomet a private or public company?

    Biomet is a Private company.

  • What is the current valuation of Biomet?

    The current valuation of Biomet is .

  • What is Biomet’s current revenue?

    The current revenue for Biomet is .

  • How much funding has Biomet raised over time?

    Biomet has raised $4.22B.

  • Who are Biomet’s investors?

    AlpInvest Partners, Blackstone, Goldman Sachs Asset Management, Kohlberg Kravis Roberts, and Ridgemont Equity Partners are 5 of 6 investors who have invested in Biomet.

  • Who are Biomet’s competitors?

    IlluminOss, Arthrex, Atec Spine, Exactech, and Orchid Orthopedic Solutions are some of the 47 competitors of Biomet.

  • When was Biomet acquired?

    Biomet was acquired on 24-Jun-2015.

  • Who acquired Biomet?

    Biomet was acquired by Zimmer Biomet Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »